COVID-19: what we are doing

Find out what ELIXIR members are doing to support the fight against COVID-19 in their countries. For a list of services ELIXIR is providing for COVID-19 research see the ELIXIR support to COVID-19 page.

ELIXIR Belgium×

ELIXIR Czech Republic×

ELIXIR Cyprus×

  • Information available soon.

ELIXIR Estonia×

ELIXIR Denmark×

ELIXIR Finland×

  • Prioritising access to national cloud and computing facilities for COVID-19 research projects.
  • Mobilised resources for the virtual COVID-19 BioHackathon.

ELIXIR France×

  • Formed a COVID-19 Task Force with national experts in bioinformatics and infrastructure provision.
  • Created a website listing the national computing infrastructures and workflows. See the IFB website.

ELIXIR Germany×

ELIXIR Greece×

ELIXIR Hungary×

  • Developed a timeline map to track the spreading of the disease to predict the outcome of the outbreak in each country.
  • Collaborating in EBI’s Data Hubs.
  • Developing COVIDoutcome, a portal to link mutation and outcome.
  • Collecting virus and blood samples from patients to investigate immune system response (n=20,000).

ELIXIR Ireland×

ELIXIR Israel×

  • Published research on COVID-19 - see the bioRxiv paper.
  • Contributed to a web page dedicated to the Coronavirus Disease 2019 on Proteopedia—the free 3D-encyclopedia of proteins and other biomolecules.


  • Created a national COVID-19 Data Portal
  • Mobilised the national compute resources to support virtual the COVID-19 BioHackathon and for on-demand Galaxy workflow support. See the Laniakea website. Release of CorGAT, a Galaxy based workflow with custom tools and utilities for the annotation of genomic variants.
  • Webinars and tutorials about Open Science and COVID-19 in collaboration with OpenAIRE, RDA, EOSC-Pillar and EOSC-Life. “Ask Me Anything” event for younger people and high-school students.
  • Intrinsically disordered proteins of SARS-CoV-2 have been manually curated and added to DisProt, see the dedicated blog post. Curation in the MINT database of molecular interactions involving proteins from SARS-CoV2, SARS and other members of the Coronaviridae family. Signor 2.0 database collected and annotated information on cellular pathways that are modulated by SARS-COV-2 infection.
  • Microbiome investigation on COVID-19 positive swab samples by applying a meta-transcriptomic approach.

ELIXIR Luxembourg×

ELIXIR Netherlands×

ELIXIR Norway×

ELIXIR Portugal×

ELIXIR Slovenia×

  • Created a national COVID-19 Data Portal
  • Developing a COVID-19 registry of patient data to enable online data collection and provide (some) compute resources for national and international research.


  • Created a national COVID-19 data portal.
  • Created a website that gathers all the efforts of ELIXIR Spain and TransBioNet members. See the Spanish National Bioinformatics Institute (INB) website.
  • Collaborative work on COVID-19 Viral Beacon, a platform allowing researchers to browse SARS-CoV-2 variability at the genome, amino acid, structural and motif level.
  • ELIXIR-ES RIR resources including the COVID-19 customisation of the text mining resource DisGeNET to identify mentions of genes, diseases, variants and phenotypes, COVID-19 and SARS-CoV-2 virus, and the 3DBIONOTES-COVID19 tool that brings together structural and functional information on SARS-CoV-2 proteome.
  • Availability of CoV-Hipathia, a web tool implementing mechanistic analysis of COVID-19-related pathways from gene expression data. CoV-Hipathia together with DisGeNet are part of COVID-19 Disease Maps, the collaborative effort led by UNILU to create, update and extend a Disease Map focused on COVID-19.

ELIXIR Sweden×

  • Created a national COVID-19 Data Portal
  • Planning the collection of human sequences (e.g. proteomics, serology) to store it securely in a local instance of the European Genome phenome Archive (EGA).

ELIXIR Switzerland×

  • Supporting COVID-19 research with databases and tools: see dedicated webpage on the SIB website.
  • Established the national infrastructure to track COVID-19 and its variants - Swiss SARS-CoV-2 Data Hub - through the Swiss Pathogen Surveillance Platform SPSP to support health authorities and boost international research.
  • Co-steering European efforts to foster open sharing of SARS-CoV-2 genomic data as part of the of the ELIXIR CONVERGE Work Package 9.
  • Provided an e-learning course for those with basic knowledge of the molecular biology of viruses to find, use or interpret information about SARS-CoV-2.


Portugal Netherlands Belgium Italy Greece Finland Germany Sweden Norway Ireland Switzerland Czech Republic Hungary Estonia France Luxembourg Slovenia UK Denmark Cyprus Spain Israel
COVID-19 Data Portal

The EBI and the European Commission have launched the European COVID-19 Data Portal. This enables the rapid collection and sharing of relevant data, in an effort to accelerate coronavirus research.


In October 2021, the BY-COVID project started. Coordinated by ELIXIR, and making use of the COVID-19 Portal, this three-year project aims to make SARS-CoV-2 and other infectious disease data easier to find and share. It is hoped that this project will enable researchers and policy makers to respond quicker to new infectious diseases.